Innovations in gene editing, expanding global diagnostic infrastructure, and strong government initiatives are driving the hemoglobinopathies market's projected 11.56% CAGR through 2032, according to ...

CRISPR Therapeutics has the potential to generate significant breakthroughs in gene editing. Regeneron's biggest growth ...

Two groundbreaking biotechnology advances are fundamentally altering human health and food production in 2025, moving from ...

Aligning with EU on genetically modified food and agricultural products will create a regulatory cliffedge for a sector which ...

Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...

Beam Therapeutics faces slow pipeline progress and high R&D costs despite a $500M cash boost. Learn why patience is key for ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

A team of researchers at Columbia, Harvard and University of Minnesota has developed a gene editing technique they say could ...

KJ Muldoon came into the world with a genetic time bomb ticking inside him.

Over the past few years, investors have moved away from somewhat speculative and unprofitable companies to put their money ...

In medical breakthrough, a baby diagnosed with rare genetic disorder is thriving after customized CRISPR gene editing therapy ...

KJ Muldoon — who was diagnosed with CPS1 deficiency at one week old — received the first-ever custom gene-editing infusion to ...